Cady K Block1, Doug Johnson-Greene2, Neil Pliskin3, Corwin Boake4. 1. a Section of Neurobehavioral Health, Department of Psychiatry and Behavioral Health , The Ohio State University , Columbus , OH , USA. 2. b Department of Physical Medicine & Rehabilitation , University of Miami Miller School of Medicine , Miami , FL , USA. 3. c Department of Psychiatry , University of Illinois at Chicago , Chicago , IL , USA. 4. d Department of Physical Medicine & Rehabilitation , The University of Texas Health Science Center at Houston , Houston , TX , USA.
Abstract
OBJECTIVE: To provide clarification on the distinction between cognitive screening, cognitive testing, and neuropsychological assessment and highlight practical implications. METHOD: Non-systematic brief clinical review. RESULTS: There is a present lack of explicit distinction between the various levels of measurement of cognitive functioning with regard to goals, indications for use, levels of complexity, and outcome. There is also a lack of guidance regarding the identification of who should be responsible for the administration and interpretation at each level. CONCLUSIONS: There is a growing awareness of the importance of cognitive health and disability, and of the importance of measurement of cognitive functions across the lifespan. For example, cognitive screening has been mandated by the Patient Protection and Affordable Care Act of 2010, and language contained within new psychiatric diagnostic criteria and healthcare regulatory changes reflect increased consideration of the importance of measurement of cognition. Changes such as these necessitate greater clarity on this important issue as it bears implications for professional practice, which ranges from education and training competencies, practice standards, and the way that neuropsychologists clarify and advocate for the value of specialty referrals for comprehensive assessment in a competitive and ever-changing healthcare market.
OBJECTIVE: To provide clarification on the distinction between cognitive screening, cognitive testing, and neuropsychological assessment and highlight practical implications. METHOD: Non-systematic brief clinical review. RESULTS: There is a present lack of explicit distinction between the various levels of measurement of cognitive functioning with regard to goals, indications for use, levels of complexity, and outcome. There is also a lack of guidance regarding the identification of who should be responsible for the administration and interpretation at each level. CONCLUSIONS: There is a growing awareness of the importance of cognitive health and disability, and of the importance of measurement of cognitive functions across the lifespan. For example, cognitive screening has been mandated by the Patient Protection and Affordable Care Act of 2010, and language contained within new psychiatric diagnostic criteria and healthcare regulatory changes reflect increased consideration of the importance of measurement of cognition. Changes such as these necessitate greater clarity on this important issue as it bears implications for professional practice, which ranges from education and training competencies, practice standards, and the way that neuropsychologists clarify and advocate for the value of specialty referrals for comprehensive assessment in a competitive and ever-changing healthcare market.
Authors: Franchesca Arias; Margaret Wiggins; Richard D Urman; Rebecca Armstrong; Kurt Pfeifer; Angela M Bader; David J Libon; Anita Chopra; Catherine C Price Journal: Perioper Care Oper Room Manag Date: 2020-01-25
Authors: Bruno Biagianti; Asia Di Liberto; Aiello Nicolò Edoardo; Ilaria Lisi; Letizia Nobilia; Giulia Delor de Ferrabonc; Elisa R Zanier; Nino Stocchetti; Paolo Brambilla Journal: Front Aging Neurosci Date: 2022-07-01 Impact factor: 5.702
Authors: Kristen Dams-O'Connor; Jessica M Ketchum; Jeffrey P Cuthbert; John D Corrigan; Flora M Hammond; Juliet Haarbauer-Krupa; Robert G Kowalski; A Cate Miller Journal: J Head Trauma Rehabil Date: 2020 Mar/Apr Impact factor: 3.117
Authors: Christina Weyer-Jamora; Melissa S Brie; Tracy L Luks; Ellen M Smith; Shawn L Hervey-Jumper; Jennie W Taylor Journal: Neurosurgery Date: 2021-11-18 Impact factor: 5.315
Authors: Lisa V Graves; Emily C Edmonds; Kelsey R Thomas; Alexandra J Weigand; Shanna Cooper; Mark W Bondi Journal: J Alzheimers Dis Date: 2020 Impact factor: 4.472